Company intelligence / Profile preview
Eleison Pharmaceuticals
Princeton, New Jersey, United Stateseleison-pharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company’s lead asset, glufosfamide, is in a pivotal international Phase III trial as a second-line treatment for metastatic pancreatic cancer. Inhaled lipid-complexed cisplatin has completed a Phase II study in pediatric osteosarcoma and will enter further studies. Dibromodulcitol rounds out the pipeline. No products are yet approved or marketed. The company leverages orphan drug designations to maximize exclusivity and pursues accelerated development pathways for late-stage assets.
- Therapeutic areas
- Oncology
- Modalities
- Small molecules (e.g., glufosfamide)Lipid-complexed chemotherapeutics (e.g., inhaled lipid-complexed cisplatin)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
BullFrog AI – collaboration to apply AI analytics to optimize clinical trials and patient selection across the pipeline, especially glufosfamide’s pivotal trial.China Oncology Focus – co-development/co-promotion agreement for glufosfamide in China/Southeast Asia.Marketing partners secured in South Korea and Israel for glufosfamide; China partner for ILC.
Beyond the preview
Go deeper on Eleison Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eleison Pharmaceuticals.